European Stocks Close Higher in Monday Trading Amid Easing Bond Yields, Oil Prices

11:58 AM EST, 11/09/2026 (MT Newswires) -- The European stock markets closed higher in Monday trading amid easing bond yields and oil prices, following President Donald Trump's remarks that could indicate a softer stance on further strikes against Iran. The Stoxx Europe climbed 1.3%, Germany's DAX advanced 1.7%, the FTSE 100 increased 1%, France's CAC rose 1.2%, and the Swiss Market Index gained 1%. In corporate news, Novartis will discontinue development of its experimental drug, pelacarsen, for atherosclerotic cardiovascular disease after a late-stage study found it did not reduce heart attacks, strokes or cardiovascular deaths, Bloomberg reported Saturday. The company will continue one trial testing the drug in patients with calcific aortic valve stenosis, a heart valve condition, Bloomberg reported. The report said the seven-year study involved 8,322 patients and found that pelacarsen significantly lowered levels of lipoprotein, an inherited cholesterol-carrying particle linked to cardiovascular disease. However, the reduction did not translate into fewer cardiovascular events, with no evidence of benefit across the patient groups analyzed, Bloomberg reported. Novartis did not immediately respond to MT Newswires' request for comment. Shares of the Swiss pharmaceutical company were up 0.3% in Zurich. Novo Nordisk said Sunday that a post hoc review of its phase 3 trial found Wegovy 2.4 mg outperformed placebo on liver tests in 106 adults with MASH and liver scarring who had a BMI below 27. At week 72, liver enzyme levels dropped 39% for ALT and 33% for AST relative to placebo, while the fibrosis marker ELF improved and PRO-C3 fell 18%, the company said. Novo said one measure of liver stiffness was not statistically significant. The company described the post hoc findings as exploratory and hypothesis-generating, noting that further research is needed to assess their clinical significance. Shares of the Danish pharmaceutical company increased 1.2% in Copenhagen. Turkcell Iletisim Hizmetleri reported Q3 earnings Monday of 3.10 Turkish lira ($0.06) per diluted share, compared with 3.21 Turkish lira a year earlier. Revenue for the quarter ended Sept. 30 was 82.04 billion Turkish lira, compared with 77.24 billion Turkish lira a year ago. Analysts polled by FactSet expect 80.73 billion Turkish lira. Shares of the company rose 2.3% higher in Monday trading. Intercontinental Exchange said Monday it plans to launch wind futures on Dec. 14 for seven European countries, subject to regulatory approval. The 15 cash-settled contracts use wind power output indices from ENWEX and cover onshore, offshore and combined generation in Denmark, France, Germany, Italy, the Netherlands, Spain and the UK, the company said. Those countries hold more than 70% of Europe's installed wind capacity, and the contracts let power market players manage wind output risk and electricity price risk, ICE said. Shares of the company edged 0.1% higher in Frankfurt. Barclays said Monday it opened a new office in Riyadh's King Abdullah Financial District after receiving an operational license from Saudi Arabia's Capital Market Authority for investment banking and global markets activities. Shares of the British lender gained 2.4% in London. BP has exited Indonesia's petrol station business after selling its entire stake in a joint fuel retail venture to AKR Group for $14.22 million, according to an AKR filing with the Indonesia Stock Exchange on Monday. BP sold its 49.9% stake in PT Aneka Petrindo Raya, or APR, its joint venture with AKR established in 2017, to two entities owned by AKR, according to a disclosure by AKR. Shares of the British oil and gas giant declined 0.6% in London.